Importantly, acetate supplementation restores IFN-γ production in hypoxic HIF1α<sup>-/-</sup> T cells and re-sensitizes HIF1α<sup>-/-</sup> tumor-bearing mice to ICBs, providing an effective strategy to overcome ICB resistance. This evidence concerns the gene HIF1A and neoplasm.